case study 41
DESCRIPTION
Case Study 41. Henry Armah, M.D., M.Phil. Question 1. Clinical history: 41-year-old male presenting with headache, mild left-sided weakness, restlessness, confusion and behavioural changes. Describe the abnormal cranial MRI findings?. Axial T1. Axial T2. Ax T1+C. Answer. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/1.jpg)
Case Study 41Henry Armah, M.D., M.Phil.
![Page 2: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/2.jpg)
Question 1Clinical history: 41-year-old male presenting with headache, mild left-sided weakness, restlessness, confusion and behavioural changes. Describe the abnormal cranial MRI findings?
![Page 3: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/3.jpg)
Axial T1
![Page 4: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/4.jpg)
Axial T2
![Page 5: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/5.jpg)
Ax T1+C
![Page 6: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/6.jpg)
AnswerLarge heterogenously contrast rim-enhancing right frontal lobe mass with central region showing no enhancement suggestive of necrosis, significant perilesional edema and significant mass effect with midline shift to the left.
![Page 7: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/7.jpg)
Question 2What are your differential diagnoses based on the patients’ age and the radiological findings?
![Page 8: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/8.jpg)
Answer1. High-grade Glioma
2. Supratentorial Primitive Neuroectodermal Tumor (PNET)
3. Abscess
4. Malignant Lymphoma
5. Metastases
![Page 9: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/9.jpg)
Question 3The neurosurgeon performs a craniotomy with resection of the mass, and requested an intraoperative consultation. Describe the microscopic findings on this smear slide?
Click here to view slide.
![Page 10: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/10.jpg)
AnswerNeoplastic proliferation of round-to-oval pleomorphic tumor cells with scant cytoplasm, scattered mitotic figures, and several apoptotic bodies.
![Page 11: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/11.jpg)
Question 4
What is your intraoperative diagnosis? (A: Category such as Defer, Reactive/Non-neoplastic, or Neoplastic; B: More specific diagnosis or statement)
![Page 12: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/12.jpg)
AnswerA. Neoplasm
B. Undifferentiated High-grade Tumor
![Page 13: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/13.jpg)
Question 5The permanent section has returned from histology. Describe the microscopic findings on this H&E slide?
Click here to view slide.
![Page 14: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/14.jpg)
AnswerFragments of a malignant neoplasm mainly composed of undifferentiated neuroepithelial cells with small round nuclei and high nucleus: cytoplasm ratios. There are focal areas of tumor cells with oval-to-elongated nuclei and fibrillary cytoplasm. There is anaplasia and brisk mitosis. Karyorrhectic, apoptotic and pyknotic nuclei are readily identified. Endothelial proliferation is noted. Rare small foci of necrosis are appreciated, but no pseudopalisading necrosis is present. Rare tumor cells with vesicular chromatin, nucleoli and Nissl substance are noted. There is no evidence of medullary-type epithelium, neuroblastic (Homer-Wright) rosettes, or ependymoblastic rosettes.
![Page 15: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/15.jpg)
Question 6What additional immunohistochemical studies would you need to rule out other important differential diagnoses and confirm the final diagnosis in this case?
![Page 16: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/16.jpg)
Answer1. GFAP
2. EGFR
3. p53
4. Ki-67 (MIB-1)
5. Synaptophysin
6. CAM5.2
7. LCA (CD45)
![Page 17: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/17.jpg)
Question 7What do you see on this GFAP immunostain slide?
Click here to view slide.
![Page 18: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/18.jpg)
AnswerGFAP strongly stains the reactive glial tissue and occasional tumor cell processes.
![Page 19: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/19.jpg)
Question 8What do you see on this EGFR immunostain slide?
Click here to view slide.
![Page 20: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/20.jpg)
AnswerEGFR is strongly and patchy positive in the tumor cells.
![Page 21: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/21.jpg)
Question 9What do you see on this p53 immunostain slide?
Click here to view slide.
![Page 22: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/22.jpg)
Answerp53 is not clonally expressed in the nuclei of tumor cells, but only positive in the nuclei of a few tumor cells.
![Page 23: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/23.jpg)
Question 10What do you see on this Ki-67 (MIB-1) immunostain slide?
Click here to view slide.
![Page 24: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/24.jpg)
AnswerKi-67 (MIB-1) is positive in the nuclei of 20-25% of the tumor cells.
![Page 25: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/25.jpg)
Question 11What do you see on this Synaptophysin immunostain slide?
Click here to view slide.
![Page 26: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/26.jpg)
AnswerSynaptophysin show focal granular and rare diffuse cytoplasmic staining of tumor cells, with no evidence of neuropil formation.
![Page 27: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/27.jpg)
Question 12What do you see on this CAM5.2 immunostain slide?
Click here to view slide.
![Page 28: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/28.jpg)
AnswerCAM5.2 is negative in tumor cells.
![Page 29: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/29.jpg)
Question 13What is your final diagnosis in this case?
![Page 30: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/30.jpg)
AnswerSupratentorial Primitive Neuroectodermal Tumor (PNET) with Glial Differentiation
![Page 31: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/31.jpg)
Question 14What is the corresponding WHO grade of this lesion?
![Page 32: Case Study 41](https://reader030.vdocument.in/reader030/viewer/2022032709/56812ff9550346895d957063/html5/thumbnails/32.jpg)
AnswerWHO Grade 4